Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-24

Clinical Trial Update: 0.5% Bupivacaine Lower Cervical Intramuscular Injection vs IV Medications for Headache Treatment [Phase 3]

View source ↗

Summary

Phase 3 trial investigating 0.5% bupivacaine injected into the lower cervical muscles for headache treatment, comparing with intravenous medications; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bupivacaine (Bupivacaine)

Snippet

Sponsor: HCA Florida North Florida Hospital | Conditions: Headache, Migraine | Phase 3 | Status: NOT_YET_RECRUITING